Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on January 9th, 2013% Emma Allen-Vercoe (University of Guelph)
Bioscientists at University of Guelph and University of Western Ontario in Canada created synthetic fecal matter for transplants that in early human trials stopped C. difficile infections. The findings of the team led by Guelph’s Emma Allen-Vercoe (pictured right) appear online in the inaugural issue of the journal . . . → Read More: Synthetic Stool Found to Stop C. Difficile Infections
By Alan, on January 8th, 2013% The vial at left holds microscopic particles of graphene oxide in a solution. At right, graphene oxide is added to simulated nuclear waste, which quickly clumps for easy removal. (Credit Anna Yu. Romanchuk/Lomonosov Moscow State University)
Researchers at Rice University in Houston and Lomonosov Moscow State University in Russia developed a lab process . . . → Read More: Graphene Oxide Absorbs Radioactive Material in Wastewater
By Alan, on January 8th, 2013% (Photos8.com)
Wake Forest Baptist Medical Center, North Carolina Eye Bank, and the company Ocular Systems Inc., all in Winston-Salem, are forming a new company to create bioengineered tissue for cornea transplants. The startup company, HCEC LLC (for human cultured endothelial cells), is expected first to advance the technology to the point of an . . . → Read More: New Company Formed to Create Engineered Corneal Tissue
By Alan, on January 8th, 2013% (NIST.gov)
Foundation Medicine, a genomic diagnostics company in Cambridge, Massachusetts, added $13.5 million to its current venture funding, bringing its series B round — the second financing cycle after start-up — to $56 million. The new investors include entrepreneurs and venture financiers Bill Gates, Evan Jones, and Yuri Milner.
Foundation Medicine, founded by . . . → Read More: Foundation Medicine Adds $13.5 Million to Series B Funds
By Alan, on January 8th, 2013% Enhanced CAT image (University of Manchester)
Materials scientists at University of Manchester in the U.K. developed a faster and more feasible 3D color X-ray system with potential uses in health care, security inspections, and industrial quality assurance. The researchers, led by Manchester’s Robert Cernik, describe their invention in the current issue of the . . . → Read More: Color X-Ray System Devised for Health, Security, Industry
By Alan, on January 7th, 2013% Engineers at Earth Networks in Germantown, Maryland developed a system for analyzing lightning occurrences during severe weather they say can increase lead times in predicting most tornados by 50 percent. Chonglin (Charlie) Liu of Earth Networks will discuss the company’s dangerous thunderstorm alert system in a presentation this week at a meeting of the American . . . → Read More: Addition of Lightning Data Increases Tornado Warning Times
By Alan, on January 7th, 2013% (U.S. Centers for Disease Control)
Illumina Inc., a developer of genetic diagnostics systems in San Diego, will acquire Verinata Health Inc. in Redwood City, California, a provider of non-invasive prenatal tests for high-risk pregnancies. The deal will pay Verinata Health $350 million, with up to $100 million in additional milestone payments through 2015.
. . . → Read More: Genetic Tech Company to Acquire Prenatal Test Developer
By Alan, on January 4th, 2013% Norfolk Southern locomotive 999 (Michael Bezilla, Pennsylvania State University)
Engineers at Pennsylvania State University in University Park wrote a new energy-reviving algorithm for lead-acid batteries that power an electric locomotive hauling freight for Norfolk Southern Railway. The team led by Penn State mechanical engineering professor Christopher Rahn describe their research, funded by Department . . . → Read More: Battery Life Extended for Working Electric Locomotive
By Alan, on January 4th, 2013% (Photos8.com)
Researchers at Copenhagen University in Denmark identified a possible cause for muscle pain encountered by people taking a leading statin drug for control of cholesterol. The team from the university’s Center for Healthy Aging, led by Flemming Dela, reported its findings in this month’s issue of the Journal of American College of . . . → Read More: Potential Cause of Statin-Produced Muscle Pain Revealed
By Alan, on January 4th, 2013% (Research.gov)
Biogen Idec, a biotechnology company in Weston, Massachusetts, reported the clinical trial of a drug to treat amyotrophic lateral sclerosis (ALS) did not meet its main objectives. Based on these results, the company decided to stop further development of dexpramipexole, the drug tested in the trial.
ALS, also known as Lou Gehrig’s . . . → Read More: Trial Fails to Show Biogen Idec ALS Drug Efficacy
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.